276 related articles for article (PubMed ID: 23146022)
1. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
2. Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection.
Zeng X; Sun YX; Qu W; Zhang XZ; Zhuo RX
Biomaterials; 2010 Jun; 31(17):4771-80. PubMed ID: 20219242
[TBL] [Abstract][Full Text] [Related]
3. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes.
Arnold GS; Sasser AK; Stachler MD; Bartlett JS
Mol Ther; 2006 Jul; 14(1):97-106. PubMed ID: 16624620
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene therapy based targeting system for the treatment of inoperable tumors.
Wirth T; Pikkarainen JT; Samaranayake HD; Lehtolainen-Dalkilic P; Lesch HP; Airenne KJ; Marjomäki V; Ylä-Herttuala SP
J Gene Med; 2012 Apr; 14(4):221-30. PubMed ID: 22411578
[TBL] [Abstract][Full Text] [Related]
5. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
[TBL] [Abstract][Full Text] [Related]
7. Use of biotinylated chitosan for substrate-mediated gene delivery.
Hu WW; Syu WJ; Chen WY; Ruaan RC; Cheng YC; Chien CC; Li C; Chung CA; Tsao CW
Bioconjug Chem; 2012 Aug; 23(8):1587-99. PubMed ID: 22768969
[TBL] [Abstract][Full Text] [Related]
8. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
Campos SK; Parrott MB; Barry MA
Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
[TBL] [Abstract][Full Text] [Related]
9. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
Purow B; Staveley-O'Carroll K
J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
[TBL] [Abstract][Full Text] [Related]
10. Development of drug targeting based on recombinant expression of the chicken avidin gene.
Walker L; Kulomaa MS; Bebok Z; Parker WB; Allan P; Logan J; Huang Z; Reynolds RC; King S; Sorscher EJ
J Drug Target; 1996; 4(1):41-9. PubMed ID: 8798877
[TBL] [Abstract][Full Text] [Related]
11. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
Morizono K; Xie Y; Helguera G; Daniels TR; Lane TF; Penichet ML; Chen IS
J Gene Med; 2009 Aug; 11(8):655-63. PubMed ID: 19455593
[TBL] [Abstract][Full Text] [Related]
12. Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide.
Zhao D; Zhuo RX; Cheng SX
Mol Biosyst; 2012 Oct; 8(12):3288-94. PubMed ID: 23086311
[TBL] [Abstract][Full Text] [Related]
13. PepFect14 peptide vector for efficient gene delivery in cell cultures.
Veiman KL; Mäger I; Ezzat K; Margus H; Lehto T; Langel K; Kurrikoff K; Arukuusk P; Suhorutšenko J; Padari K; Pooga M; Lehto T; Langel Ü
Mol Pharm; 2013 Jan; 10(1):199-210. PubMed ID: 23186360
[TBL] [Abstract][Full Text] [Related]
14. Peptide-based vectors mediated by avidin-biotin interaction for tumor targeted gene delivery.
Qu W; Qin SY; Kuang Y; Zhuo RX; Zhang XZ
J Mater Chem B; 2013 Apr; 1(16):2147-2154. PubMed ID: 32260847
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.
Chen JX; Xu XD; Yang S; Yang J; Zhuo RX; Zhang XZ
Macromol Biosci; 2013 Jan; 13(1):84-92. PubMed ID: 23281275
[TBL] [Abstract][Full Text] [Related]
16. Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein.
Lehtolainen P; Wirth T; Taskinen AK; Lehenkari P; Leppänen O; Lappalainen M; Pulkkanen K; Marttila A; Marjomäki V; Airenne KJ; Horton M; Kulomaa MS; Ylä-Herttuala S
Gene Ther; 2003 Dec; 10(25):2090-7. PubMed ID: 14595382
[TBL] [Abstract][Full Text] [Related]
17. Conditional expression of Lodavin, an avidin-tagged LDL receptor, for biotin-mediated applications in vivo.
Murugan S; Saarela U; Airenne K; Shan J; Skovorodkin I; Ylä-Herttuala S; Vainio SJ
Genesis; 2012 Sep; 50(9):693-9. PubMed ID: 22467513
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery via avidin fusion protein: intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes.
Soininen SK; Lehtolainen-Dalkilic P; Karppinen T; Puustinen T; Dragneva G; Kaikkonen MU; Jauhiainen M; Allart B; Selwood DL; Wirth T; Lesch HP; Määttä AM; Mönkkönen J; Ylä-Herttuala S; Ruponen M
Eur J Pharm Sci; 2012 Dec; 47(5):848-56. PubMed ID: 22985874
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
Huang H; Yu H; Tang G; Wang Q; Li J
Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
[TBL] [Abstract][Full Text] [Related]
20. Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.
Moffatt S; Papasakelariou C; Wiehle S; Cristiano R
Gene Ther; 2006 May; 13(9):761-72. PubMed ID: 16453011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
